PeptMentor
CalculatorsHow we source
PeptMentor
PeptMentor
Peptides
Eloralintide
Retatrutide
GHK-Cu
Pinealon
KPV
KLOW
All peptides
Compared
Eloralintide vs cagrilintide
Eloralintide vs retatrutide
Retatrutide vs tirzepatide
Guides and tools
Bac water for peptides
How to reconstitute peptides
Peptide reconstitution calculator
All guides
About
How we source
About
Editorial policy
Open the peptide calculator
PeptMentor

Plain answers about peptides and GLP-1 medicines. Every figure links to its source and says what kind of study it came from.

No dose advice. No sponsors, sellers or affiliate codes.

Peptides

  • Eloralintide
  • GHK-Cu
  • KLOW
  • KPV
  • Pinealon
  • Retatrutide
  • All peptides

Compare

  • Eloralintide vs cagrilintide
  • Eloralintide vs retatrutide
  • Retatrutide vs tirzepatide

Guides and tools

  • Peptide reconstitution calculator
  • Bac water for peptides
  • How to reconstitute peptides
  • All guides

About us

  • About
  • How we check facts
  • Editorial policy
  • Sources
  • Contact
© 2026 PeptMentor LLC. For information only, not medical advice. In an emergency call 911.
Medical disclaimerTermsPrivacyConsumer health data
  1. /Home
  2. /Peptides
  3. /KPV

Tiny peptide · inflammation · animal studies only

KPV peptide: what it is, and what we know and don't

A tiny peptide studied for gut and skin inflammation in cells and animals, never in people. Whether you are curious, starting, or already using it, here is what helps.

Two friends sharing a simple healthy lunch by a window
StatusNot FDA approved
How sure is science?Animal studies only
What studies looked atGut inflammation in mice
Human trialsNone, FDA found no human data

Status as of November 17, 2026. For information only, not medical advice: read the medical disclaimer.

Where are you with KPV?

Before you decide

Good place to start. Here is what we would want to know before deciding, in plain words.

It has never been tested in people

FDA’s 2026 review found no human study, no human safety data and no case reports. So nobody knows if KPV works in people, what amount is safe, or what side effects it has.

RegulatorWhat FDA found →

What it did in animals

Most studies gave KPV to mice with gut inflammation, often in drinking water or tiny carrier particles. Plain KPV taken by mouth did nothing in one 2026 mouse study.

AnimalEvery study →

Nasal sprays and shots: no study at all

No study of any kind has tested KPV as a nasal spray or a shot, in animals or people. In lab tests, it did not get through unbroken human skin.

Which forms were tested →

Its legal status is still a draft

KPV is not FDA approved. A 2026 US draft policy covers only skin and by-mouth KPV acetate from a pharmacy, per law-firm summaries. It is not final.

Status and timeline →

Take these questions to your doctor

  • Is there an approved treatment for my condition, with human trial data?
  • KPV has never been tested in people. How would we judge if it helps or harms me?
  • Could it affect my other medicines or my current treatment?
  • What signs would make you want me to stop?

Coming Pick your questions and print them as one page.

Your first weeks

There is no trial to lean on here. No study has given KPV to people, so nobody knows the right amount, the side effects or how long to take it. Here is what still helps.

There is no human dose

No one has studied KPV in people, so there is no dose to point to. The amounts in animal studies are not a guide for people. Any dose question belongs with your doctor.

Why no dose exists →

Mixing a vial? Do the maths first

The calculator turns the numbers on your own label into units on a syringe. It never suggests an amount.

Open the calculator →

Keep things clean

If you mix a powder, clean technique matters. Our step-by-step guide covers it.

How to reconstitute peptides →

Write down your starting point

Note the product name, its form and the strength on the label. Write down the symptom you hope to change, and give it a score from 0 to 10.

What to track →

Living with it

You’re using it. No trial has tested KPV in people, so nobody knows the right amount, the side effects or how long to take it. Here is how to keep track and stay safer.

Have a gut or skin condition?

KPV has no human evidence for any condition. It is not a swap for treatment that has been tested in people. Talk to your doctor before you change anything.

Questions for your doctor →

Is it working?

These are notes for your doctor, not a medical test.

  • Score your symptom from 0 to 10 on the same day each week.
  • Take photos of any skin area in the same light and spot.
  • Note any new symptom, with the date.

Mixing it with other peptides?

No study has tested KPV with any other peptide, so nobody can say what a mix does.

What is known →

Got it online? Lower the risk.

No judgement. We won’t tell you where to buy or how much to take, but these steps lower the risk whatever you use:

  • A label saying “research use only” or “not for human consumption” means it was not made or checked for people.
  • If you mix a powder, use clean technique every time. See how to reconstitute peptides.
  • Tell your doctor what you are taking, even if it feels awkward. It changes what they watch for.
  • Report a bad reaction to the FDA’s MedWatch. It helps everyone.
Source: FDA MedWatch[1]

When to get help

KPV has no drug label and no human side-effect data, so there is no official list of warning signs. Here is what is known.

Emergency: call 911 (or your local emergency number). Possible overdose or wrong amount: Poison Help, 1-800-222-1222, free and open 24 hours. Report a bad reaction to the FDA through MedWatch.

Talk to a doctor or pharmacist if

  • You feel unwell after using any product. Bring the product label with you.
  • You notice a new symptom you cannot explain. FDA flags a possible immune reaction, where your body’s defences react to the peptide.
What is known about side effects →

Be wary of side-effect lists online

Lists of KPV side effects on other sites, such as redness where you inject or a sore nose, cite no source. Nobody has measured them.

What FDA says about safety →

Report what happened

If you had a bad reaction, you or your doctor can report it to the FDA’s MedWatch.

Source: FDA MedWatch[1]

The science, if you want it

Every number below says what kind of study it came from. Bracketed numbers point to the sources listed at the end.

Cell and animal onlyNo human studiesNot FDA approved
CellAnimalSmall humanHuman randomised trialApproved

Best evidence: animal

Facts checked 2026-11-17 · by PeptMentor Team · How we source

On this page
At a glanceWhat to expect over timeLiving with it day to day: what 'animal only' means for youSide effects: what's known and when to get helpIs it working? How to track itYour appointment checklistWhat is KPV?How KPV works: what is known and what is notWhat has been studiedHas KPV been tested in humans?KPV doses: no human dose existsKPV vial calculator: arithmetic onlyWhich routes have been studied?Side effects and safetyIs KPV legal? FDA and compounding statusCombining KPV with other peptidesKPV: questions people askSources

At a glance

Key takeaways
  • KPV has been tested only in cells and animals, mostly in mice with gut inflammation.
  • FDA found no human study, no human safety data and no case reports.RegulatorFDA KPV briefing, July 2026[2]
  • So no one knows if it works in people, what amount is safe, or what side effects it has.
  • Plain KPV taken by mouth did nothing in one 2026 mouse study.Animal[3]
  • A 2026 US draft policy covers only skin and by-mouth forms, per law-firm summaries.RegulatorMcDermott summary, 2026-11-02[4]
I'm…New to itWorried about a side effectAsked about shots or nasal sprayLiving with a skin or gut condition

What to expect over time

KPV has never been given to people in a study, so there is no human time course at all. Any KPV timeline you see online has no study behind it.

Living with it day to day: what 'animal only' means for you

What 'cell and animal only' means. Every KPV result comes from cells in a dish or from mice, rats and rabbits. These studies show why scientists are interested. They cannot tell you if KPV works in people, what amount to use, or what harm it might do.

No safety testing either. FDA found no toxicity studies of any kind, in animals or people[2]. Toxicity studies are the tests that look for harm, such as damage to genes, effects on having children, or cancer.

The form matters, and it has barely been tested. Most mouse studies put KPV in drinking water or in tiny carrier particles. Plain KPV by mouth did nothing in one 2026 mouse study[3]. In lab tests on human skin samples, KPV did not get through unbroken skin[5]. No study of any kind has tested a nasal spray or a shot.

No label. KPV has no approved drug label, so there is no official guide to storage, travel or daily use.

Side effects: what's known and when to get help

There are no human side-effect data, because no study has given KPV to people. FDA says the risks to people "are unknown". It flags a possible immune reaction, meaning your body's defences react to the peptide[2]. Lists of KPV side effects on other sites cite no source.

We do not show a tips list or a list of warning signs here. KPV has no drug label, and we do not make one up. If you feel unwell after any product, talk to a doctor or pharmacist and bring the product label.

Is it working? How to track it

Notes worth keeping if you already use it
  • The product name, its form (cream, capsule or other) and the strength on the label.
  • The symptom you hope to change, written down before you start.
  • A simple score for that symptom, such as 0 to 10, on the same day each week.
  • Photos of any skin area, in the same light and spot each time.
  • Any new symptom, with the date.

This is a way to keep notes for your doctor, not a medical test.

Your appointment checklist

Bring these to your appointment
  • Is there an approved treatment for my condition, with human trial data?
  • KPV has never been tested in people. How would we judge if it helps or harms me?
  • Could it affect my other medicines or my current treatment?
  • What form is this product, and is that form covered by the 2026 draft policy?
  • What signs would make you want me to stop?

Any dose question belongs here. No human dose has been studied, so there is no trial figure to point to[2].

What is KPV?

What it is, its chemistry and who studies it.
KPV in short

What it is: the tripeptide Lys-Pro-Val, positions 11 to 13 of alpha-MSH[6]. Evidence: cell and animal only; no human data[2]. Status: not FDA approved and not on the 503A list. The HHS draft policy of 2026-10-30 covers KPV acetate for topical and oral use only, per law-firm summaries[4].

0

Human studies of KPV found by FDA, July 2026[2]

Regulator
3

Amino acids: lysine, proline, valine[6]

Cell
8-6-1

FDA advisory committee vote to recommend KPV for the 503A list, 2026-07-23[7]

Regulator
Best evidence so far
CellAnimalSmall humanHuman randomised trialApproved

Best evidence: animal

KPV reaches animal studies. No human study exists (FDA review, July 2026).

A fragment of alpha-MSH. Alpha-MSH is a 13-amino-acid hormone made from a larger precursor called POMC. KPV is its last three amino acids. According to a 2008 review, KPV keeps alpha-MSH's anti-inflammatory effect in lab models but lacks its pigment (tanning) effect[8]. Chemistry: formula C16H30N4O4, molecular weight 342.43, CAS 67727-97-3[6].

Who studies it. No company develops KPV. It is an academic research compound, studied mainly by groups in Münster, Germany, and at Emory and Georgia State in the US[8][9]. No KPV product is authorised by the EMA, and there is no European or Japanese pharmacopoeia monograph[2].

FeatureKPVAlpha-MSH
Length3 amino acids[6]13 amino acids[8]
Pigment (tanning) effectNo[8]Yes[8]
Raises cAMPNo[10]Yes[10]

How KPV works: what is known and what is not

Lab findings on how it might work; the target is unknown.
FindingSourceStudy type
Nanomolar KPV blocked NF-κB and MAP kinase signalling in human gut cells and T cells[9]Cell
KPV enters cells through the PepT1 transporter, which rises in the inflamed colon[9]Cell
KPV did not raise cAMP; authors judged melanocortin receptors "unlikely" to explain its effect[10]Animal
KPV raised calcium, not cAMP, in human skin cells[11]Cell
KPV blocked NF-κB p65 from entering the nucleus in airway cells[12]Cell

FDA's 2026 review concluded that the molecular targets behind KPV's effects "remain unknown" (p. 25)[2]. Many sites describe KPV as an MC1R or MC3R agonist. The primary studies and FDA's review do not support that, so the honest answer is that the mechanism is not settled.

What has been studied

Every animal and cell study, with results.

Every study below is in animals or cells. None tells you what KPV does in people.

ModelWhat was foundSourceStudy type
Mouse colitis (DSS, TNBS), KPV in drinking waterLess weight loss; inflammation marker MPO down about 50% (DSS) and 30% (TNBS)[9]Animal
Mouse colitis, including mice lacking MC1RFaster recovery, partly independent of MC1R[13]Animal
Mouse colitis, KPV in nanoparticles in a gelSimilar effect to free KPV at a 12,000-fold lower concentration[14]Animal
Mouse colitis, oral hyaluronic-acid nanoparticlesFaster gut-lining healing, lower TNF-α[15]Animal
Mouse colitis-associated cancerFewer tumours in normal mice; no effect in mice lacking PepT1[16]Animal
Mouse colitis, oral prodrug studyFree KPV at 1 mg/kg by mouth showed no benefit; the prodrug did[3]Animal
Rabbit corneal scratch, eye drops8 of 8 treated corneas healed at 60 hours vs 0 with placebo[17]Animal
Rat mouth sores from chemotherapy, KPV gelBetter healing, lower IL-1β and TNF-α[18]Animal
Bacteria and yeast in cultureLess growth of S. aureus and C. albicans[19]Cell

Gut inflammation. Most KPV research is in mouse colitis. Later papers focus on delivery systems such as nanoparticles and gels, because free KPV is poorly delivered. In one 2026 study, plain KPV by mouth did nothing in mice[3].

Skin, cornea and mouth. The skin evidence is skin cells in a dish and skin samples in a lab. In a lab test on human skin samples, KPV did not pass through intact skin at a detectable level; it only got through with microneedles[5]. The cornea and mouth results are from rabbits and rats.

Psoriasis and seborrheic dermatitis: no studies found. A PubMed search on 2026-11-17 found no study of KPV in psoriasis or seborrheic dermatitis, in people or in animals. A compounding pharmacy proposed KPV for psoriasis and eczema when it nominated it to FDA; FDA found no human data on KPV for any use[2].

Has KPV been tested in humans?

FDA’s 2026 review: no human data of any kind.

No. ClinicalTrials.gov searches for KPV, Lys-Pro-Val, alpha-MSH tripeptide and KdPT on 2026-11-17 found no KPV trial. PubMed has no study that gave KPV to people. FDA's July 2026 review reached the same conclusion (pp. 20 to 26)[2]:

  • no clinical studies in humans;
  • no human pharmacokinetic data by any route;
  • no reports in FDA's adverse event database (FAERS) up to 2025-12-03, and no case reports;
  • no toxicity studies of any kind: acute, repeat-dose, genetic, reproductive or cancer.

The closest work to people uses human cells or tissue outside the body: blood from people with HIV treated in a dish[20], skin samples in a diffusion cell[5] and a 3D skin model[21].

KPV doses: no human dose exists

Animal and cell amounts as published, not converted.
No human dose has been studied
KPV has never been studied in people, so there is no studied human dose. FDA found no human pharmacokinetic data by any route (July 2026)[2].

Amounts used in animal and cell studies (not converted). These are reported as published. They are not converted to human amounts and are not a guide for people.

StudySpecies or systemRouteAmount as publishedHow longStudy type
Dalmasso 2008[9]Mouse colitisDrinking water100 µM KPV in water8 days (DSS); 48 h (TNBS)Animal
Viennois 2016[16]Mouse colitis-associated cancerDrinking water100 µmol/L KPV in waterTwo 7-day DSS cyclesAnimal
Xiao 2017[15]Mouse colitisBy mouth, in nanoparticles16 µg/kg per day5 daysAnimal
Cheng 2026[3]Mouse colitisBy mouthFree KPV 1 mg/kg (no benefit); prodrug 0.5 and 2.5 mg/kg7 daysAnimal
Bonfiglio 2006[17]Rabbit corneaEye drops1, 5 or 10 mg/mL, 4 times a day4 daysAnimal
Sung 2025[21]Human skin cellsIn a dish50 µg/mL24 hCell
Dalmasso 2008[9]Human gut cells and T cellsIn a dishNanomolar (for example 10 nM)HoursCell

Animal and cell amounts only. Not converted, not a human dose.

We do not include community dose ranges. None of them comes from a study.

KPV vial calculator: arithmetic only

No human dose of KPV has been studied
This tool turns the numbers on your own label into concentration and syringe units. It does not suggest an amount, and the animal amounts above are not a guide for people.

Before you use the calculator

  • It does arithmetic on the numbers you type from your own label. It does not suggest an amount or say whether anything is safe for you.
  • It is not medical advice. Check every result with your pharmacist or prescriber before you use it.
  • Its units are for U-100 insulin syringes only (the box or barrel says U-100).
  • In an emergency call 911. For a possible overdose call Poison Help at 1-800-222-1222.

Your answer is saved only in this browser so you are not asked again. See the privacy policy.

There is no approved KPV product or label, so nothing is preset: type the mg on your own vial. Mixing steps: how to reconstitute peptides.

Which routes have been studied?

Oral, eye, skin, nasal and injection: what was tested.
RouteWhat has been studiedStudy typeIn the HHS draft policy?
OralMice: drinking water and nanoparticles; free KPV at 1 mg/kg failed[3]AnimalYes, as KPV acetate[4]
Eye dropsRabbits[17]AnimalNo
SkinDid not pass through human skin samples without microneedles[5]Cell (tissue in a lab)Yes, as KPV acetate[4]
Mouth (gel)Rats[18]AnimalNot stated in the summaries
NasalNo published study foundNoneNo
InjectionNo published study foundNoneNo

So for nasal or injected KPV, there is no study at all, in animals or people. The HHS draft policy is a draft, and its route details come from law-firm summaries; we have not been able to read the appendix itself.

Side effects and safety

What FDA says about safety and what is missing.

There are no human side-effect data because no human study exists. FDA found no FAERS reports and no case reports, and says the potential risks to people "are unknown". It flags immune reactions and peptide clumping as concerns that have not been assessed (pp. 26 to 27)[2]. No toxicity study of any kind has been done.

The animal papers do not report harm in their abstracts. They were short studies of effect, not safety studies, so that is not a safety finding. Lists of KPV side effects on other sites, such as injection-site redness or nasal irritation, cite no source.

Is KPV legal? FDA and compounding status

Dated FDA and HHS status, and WADA.

KPV is not FDA approved and is not on the 503A bulks list. A compounding pharmacy network nominated it for topical creams and gels, then withdrew the nomination (pp. 4 to 6)[2]. We have not found the date KPV was first placed in category 2.

  1. 2026-04-15

    BPC-157, TB-500, KPV and injectable GHK-Cu leave FDA category 2 because their nominators withdrew them. Leaving the list does not make them legal to compound.

    Frier Levitt summary of the FDA notice[22] Regulator
  2. 2026-04-22

    FDA's safety page lists KPV as "nominated but withdrawn" and says FDA has not identified any human exposure data for KPV by any route.

    FDA safety-risk page[23] Regulator
  3. 2026-07

    FDA staff propose that neither KPV free base nor KPV acetate be added to the 503A list: poorly characterised, unknown extent of use, no human data.

    FDA briefing documents for the advisory committee[24] Regulator
  4. 2026-07-23

    FDA advisory committee votes 8-6-1 to recommend BPC-157, KPV and TB-500 for the 503A list, against FDA staff advice. The vote is advisory.

    McDermott summary of the meeting[7] Regulator
  5. 2026-10-30

    HHS publishes a draft enforcement-discretion policy for compounding certain peptides. Per law-firm summaries, KPV is covered as KPV acetate, topical and oral only, single-ingredient products only.

    Federal Register 91 FR 68526; McDermott summary of Appendix A[25] Regulator

Can a pharmacy compound KPV in 2026? The HHS policy is a draft. Its comment period closed about two weeks after publication, and we will update this page if a final version is issued. Per law-firm summaries[4], it covers only topical and oral KPV acetate in single-ingredient products. Injected and nasal KPV are outside it. We found no FDA warning letter or import alert naming KPV, though our search was not exhaustive.

Sport (WADA). KPV is not named on the WADA Prohibited List[26]. The S0 catch-all for substances without government approval for human therapeutic use probably applies. That is our reading, not a WADA ruling; athletes should check with their anti-doping body. A 2026 review lists KPV among peptides used in sport[27].

Combining KPV with other peptides

No published study has tested KPV with CJC-1295, ipamorelin, GHK-Cu, Melanotan 1 or any other peptide. FDA notes that clinics promote KPV in multi-peptide "regenerative" combinations (p. 19)[2]. Per law-firm summaries, the HHS draft policy covers only single-ingredient products, so a compounded mix that includes KPV falls outside it.

KPV is one of four peptides in the KLOW blend, alongside GHK-Cu, BPC-157 and TB-500.

KPV: questions people ask

Direct answers to what people search for. Bracketed numbers point to the sources at the end; the sections above have the detail.

What is KPV, in simple terms?

A tiny peptide of three amino acids, taken from the end of the hormone alpha-MSH. In lab models it keeps the hormone's effect on inflammation but not its tanning effect[8].

Has anyone tested KPV in people?

No. FDA's July 2026 review found no human studies, no data on how the body handles it and no case reports[2].

Is KPV an approved drug?

No. It is not approved and is not on FDA’s 503A list. An FDA advisory group voted to recommend adding it, but that vote does not decide anything.

Can my pharmacy make KPV for me?

Only in some forms, and only under a draft. Law-firm summaries say the HHS draft from October 2026 covers KPV acetate as a skin or by-mouth product with one active part[4]. It is not final yet.

Will KPV help my psoriasis or seborrheic dermatitis?

No one knows. No study of KPV in either condition has been published, in people or animals (PubMed, 2026-11-17).

Can I take KPV by mouth, as a nasal spray or as a shot?

None of these has been tested in people. By mouth was tested in mice only, and plain KPV failed in one 2026 study. No nasal or injected study exists.

Can I use KPV with CJC-1295, ipamorelin or GHK-Cu?

There is no data. No study has tested KPV with any of them.

I compete in sport. Is KPV banned?

It is not named on the WADA list. But WADA’s S0 rule for unapproved substances probably covers it. Check with your anti-doping body.

Sources

  1. 1.FDA MedWatch
  2. 2.FDA KPV briefing document, July 2026 Regulator
  3. 3.Cheng 2026, oral prodrug in mice (PMID 41533788) Animal
  4. 4.McDermott summary of the HHS policy appendix, 2026-11-02 Regulator
  5. 5.Pawar 2017, human skin permeation (PMID 28343991) Cell
  6. 6.PubChem CID 125672, KPV Cell
  7. 7.McDermott summary of the PCAC meeting, 2026-07-27 Regulator
  8. 8.Brzoska 2008, alpha-MSH review (PMID 18612139) Animal
  9. 9.Dalmasso 2008, gut cells and mouse colitis (PMID 18061177) Animal
  10. 10.Getting 2003, mechanism (PMID 12750433) Animal
  11. 11.PMID 15102092
  12. 12.PMID 22837805
  13. 13.Kannengiesser 2008, mouse colitis (PMID 18092346) Animal
  14. 14.PMID 19909746
  15. 15.PMID 28143741
  16. 16.PMID 27458604
  17. 17.Bonfiglio 2006, rabbit cornea (PMID 16965771) Animal
  18. 18.PMID 34846053
  19. 19.PMID 10670585
  20. 20.PMID 9700761
  21. 21.PMID 40073467
  22. 22.Frier Levitt summary of the FDA notice
  23. 23.FDA: bulk substances that may present significant safety risks Regulator
  24. 24.FDA introductory briefing document, July 2026 Regulator
  25. 25.HHS draft peptide policy, 91 FR 68526 Regulator
  26. 26.WADA Prohibited List
  27. 27.PMID 41880199
On this pageAt a glanceWhat to expect over timeLiving with it day to day: what 'animal only' means for youSide effects: what's known and when to get helpIs it working? How to track itYour appointment checklistWhat is KPV?How KPV works: what is known and what is notWhat has been studiedHas KPV been tested in humans?KPV doses: no human dose existsKPV vial calculator: arithmetic onlyWhich routes have been studied?Side effects and safetyIs KPV legal? FDA and compounding statusCombining KPV with other peptidesKPV: questions people askSources